INSR and bipolar disorder: In a 2022 case study of treatment-resistant bipolar depression, reversal of insulin resistance with metformin was accompanied by restoration of blood–brain barrier integrity and full symptomatic remission, implicating brain insulin-receptor signalling in mood restoration [131].